Skip to Main content Skip to Navigation
Journal articles

Lung cancer: a modified epigenome

Abstract : Epigenetic is the study of heritable changes in gene expression that occur without changes in DNA sequence. This process is important for gene expression and genome stability and its disruption is now thought to play a key role in the onset and progression of numerous tumor types. The most studied epigenetic phenomena includes post-translational modifications in DNA and histone proteins as well as microRN As expression. As epigenetic aberrations are potentially reversible, their correction has emerged as a potential strategy for the treatment of cancer. This review highlights the roles of chromatin epigenetic modifications and of microRN As expression in lung tumorigenesis and discusses the emerging epigenetic therapies which are being developed for the treatment of lung cancer.
Document type :
Journal articles
Complete list of metadata

Cited literature [95 references]  Display  Hide  Download
Contributor : Beatrice Eymin Connect in order to contact the contributor
Submitted on : Tuesday, October 29, 2019 - 2:40:50 PM
Last modification on : Friday, November 6, 2020 - 3:56:53 AM
Long-term archiving on: : Thursday, January 30, 2020 - 7:17:30 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Arnaud van den Broeck, Peggy Ozenne, Beatrice Eymin, Sylvie Gazzeri. Lung cancer: a modified epigenome. Cell Adhesion and Migration, Taylor & Francis, 2010, 4 (1), pp.107-113. ⟨10.4161/cam.4.1.10885⟩. ⟨inserm-02337479⟩



Record views